465 related articles for article (PubMed ID: 9274464)
1. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.
Gut; 1997 Jul; 41(1):8-13. PubMed ID: 9274464
[TBL] [Abstract][Full Text] [Related]
2. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G;
Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399
[TBL] [Abstract][Full Text] [Related]
3. The Maastricht recommendations and their impact on general practice.
Malfertheiner P
Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S63-7; discussion S73. PubMed ID: 10503826
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
[TBL] [Abstract][Full Text] [Related]
5. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
6. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
8. Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.
Boixeda D; Martín De Argila C; Bermejo F; López Sanromán A; Hernández Ranz F; García Plaza A
Rev Esp Enferm Dig; 2003 Mar; 95(3):206-9, 202-5. PubMed ID: 12760710
[TBL] [Abstract][Full Text] [Related]
9. Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer.
McColl KE; el-Nujumi A; Murray LS; el-Omar EM; Dickson A; Kelman AW; Hilditch TE
Gut; 1998 May; 42(5):618-22. PubMed ID: 9659153
[TBL] [Abstract][Full Text] [Related]
10. Guidelines in the management of Helicobacter pylori infection in Japan.
Asaka M; Satoh K; Sugano K; Sugiyama T; Takahashi S; Fukuda Y; Ota H; Murakami K; Kimura K; Shimoyama T
Helicobacter; 2001 Sep; 6(3):177-86. PubMed ID: 11683920
[TBL] [Abstract][Full Text] [Related]
11. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
Misiewicz JJ; Harris AW; Bardhan KD; Levi S; O'Morain C; Cooper BT; Kerr GD; Dixon MF; Langworthy H; Piper D
Gut; 1997 Dec; 41(6):735-9. PubMed ID: 9462204
[TBL] [Abstract][Full Text] [Related]
12. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
13. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
14. Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin.
Toracchio S; Capodicasa S; Soraja DB; Cellini L; Marzio L
Dig Liver Dis; 2005 Jan; 37(1):33-8. PubMed ID: 15702857
[TBL] [Abstract][Full Text] [Related]
15. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.
Malfertheiner P; Megraud F; O'Morain C; Bazzoli F; El-Omar E; Graham D; Hunt R; Rokkas T; Vakil N; Kuipers EJ
Gut; 2007 Jun; 56(6):772-81. PubMed ID: 17170018
[TBL] [Abstract][Full Text] [Related]
16. Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial.
Metanat HA; Valizadeh SM; Fakheri H; Maleki I; Taghvaei T; Hosseini V; Bari Z
Helicobacter; 2015 Aug; 20(4):299-304. PubMed ID: 25752357
[TBL] [Abstract][Full Text] [Related]
17. Guidelines in the medical treatment of Helicobacter pylori infection.
Dzieniszewski J; Jarosz M
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
[TBL] [Abstract][Full Text] [Related]
18. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
19. [Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies].
Bigard MA
Presse Med; 2001 Sep; 30(26):1305-12. PubMed ID: 11603094
[TBL] [Abstract][Full Text] [Related]
20. One-week low-dose triple therapy vs. two-week medium-dose double therapy for H.pylori infection.
Tursi A; Cammarota G; Papa A; Montalto M; Veneto G; Capelli G; Cuoco L; Branca G; Fedeli G; Gasbarrini G
Hepatogastroenterology; 1996; 43(10):859-62. PubMed ID: 8884304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
